Inozyme Pharma Inc. (INZY): Price and Financial Metrics


Inozyme Pharma Inc. (INZY): $2.42

0.16 (+7.08%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INZY to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

INZY Stock Price Chart Interactive Chart >

Price chart for INZY

INZY Price/Volume Stats

Current price $2.42 52-week high $7.98
Prev. close $2.26 52-week low $0.99
Day low $2.20 Volume 570,664
Day high $2.54 Avg. volume 283,285
50-day MA $1.54 Dividend yield N/A
200-day MA $3.03 Market Cap 97.75M

Inozyme Pharma Inc. (INZY) Company Bio


Inozyme Pharma engages in the research and development of pharmaceutical products. It specializes in developing new medicines for the treatment of abnormal mineralization and ABCC6 deficiency. The company was founded by Axel Bolte, Joseph P. Schlessinger and Demetrios T. Braddock in September 2015 and is headquartered in Boston, MA.


INZY Latest News Stream


Event/Time News Detail
Loading, please wait...

INZY Latest Social Stream


Loading social stream, please wait...

View Full INZY Social Stream

Latest INZY News From Around the Web

Below are the latest news stories about INOZYME PHARMA INC that investors may wish to consider to help them evaluate INZY as an investment opportunity.

Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress

- Company to share topline data from ongoing Phase 1/2 trials of INZ-701 in ENPP1 Deficiency and ABCC6 Deficiency at virtual event on Thursday, Feb. 16, 2023 – - Significant clinical and scientific milestones across ENPP1 Deficiency and ABCC6 Deficiency programs achieved in 2022 - BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and in

Yahoo | January 9, 2023

Can you still get a good price for Inozyme Pharma Inc. (INZY) Shares at this point?

Inozyme Pharma Inc. (NASDAQ:INZY) marked $1.05 per share on Friday, down from a previous closing price of $1.14. While Inozyme Pharma Inc. has underperformed by -7.89%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INZY fell by -84.89%, with highs and lows ranging from $7.98 to […]

US Post News | January 3, 2023

Is Inozyme Pharma Inc. (INZY) a opportunity to investors?

As of Wednesday, Inozyme Pharma Inc.’s (NASDAQ:INZY) stock closed at $1.45, up from $1.26 the previous day. While Inozyme Pharma Inc. has overperformed by 15.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INZY fell by -78.74%, with highs and lows ranging from $8.27 to $1.19, […]

US Post News | December 8, 2022

Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency

- Article in Orphanet Journal of Rare Diseases estimates genetic prevalence of ENPP1 Deficiency at 1 in 64,000 pregnancies, more than tripling prior estimate - - Company estimates addressable patient population with ENPP1 Deficiency at 37,000 worldwide; 2,800 in North America, 4,100 in Europe and 900 in Japan - BOSTON, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of p

Yahoo | December 5, 2022

Inozyme Pharma to Participate at the BofA Securities Biotech SMID Cap Conference

BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Axel Bolte, MSc, MBA, the company’s co-founder, president, and chief executive officer, will participate in a fireside chat at the BofA Securities Biotech SMID Cap Conference on Thursday, December 8, 2022, from 8:00-8:30am ET. A replay of the fi

Yahoo | December 1, 2022

Read More 'INZY' Stories Here

INZY Price Returns

1-mo 130.48%
3-mo 59.21%
6-mo -32.21%
1-year -63.77%
3-year N/A
5-year N/A
YTD 130.48%
2022 -84.60%
2021 -66.96%
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6071 seconds.